APA

Spisni E., Valerii M. C., De Fazio L., Cavazza E., Borsetti F., Sgromo A., Candela M., Centanni M., Rizello F. & Strillacci A. (20160224). Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Spisni Enzo, Valerii Maria C, De Fazio Luigia, Cavazza Elena, Borsetti Francesca, Sgromo Annamaria, Candela Marco, Centanni Manuela, Rizello Fernando and Strillacci Antonio. 20160224. Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Spisni E., Valerii M. C., De Fazio L., Cavazza E., Borsetti F., Sgromo A., Candela M., Centanni M., Rizello F. and Strillacci A. (20160224). Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Spisni Enzo, Valerii Maria C, De Fazio Luigia, Cavazza Elena, Borsetti Francesca, Sgromo Annamaria, Candela Marco, Centanni Manuela, Rizello Fernando and Strillacci Antonio. Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. : Molecular therapy : the journal of the American Society of Gene Therapy. 20160224.